Women’s barrier contraceptive methods as modern methods

AIDS Research and Treatment

Stein

2012

Self Cite

A recent multi-country study on hormonal contraceptives (HC) and HIV acquisition and transmission among African HIV-serodiscordant couples reported a statistically significant doubling of risk for HIV acquisition among women as well as transmission from women to men for injectable contraceptives. Together with a prior cohort study on African women seeking health services, these data are the strongest yet to appear on the HC-HIV risk. This paper will briefly review the Heffron study strengths and relevant biological and epidemiologic evidence; address the futility of further trials; and propose instead an alternative framework for next steps. The weight of the evidence calls for a discontinuation of progestin-dominant methods. We propose here five types of productive activities: (1) scaling injectable hormones down and out of the contraceptive mix; (2) strengthening and introducing public health strategies with proven potential to reduce HIV spread; (3) providing maximal choice to reduce unplanned pregnancy, starting with quality sexuality education through to safe abortion access; (4) expanding provider training, end-user counseling and access to male and female barriers, with a special renewed focus on female condom; (5) initiating a serious research agenda to determine anti-STI/HIV potential of the contraceptive cervical cap. Trusting women to make informed choices is critical to achieve real progress in dual protection.

Section: Next Steps: Living With Uncertainty Acting In Best Intermentioning

confidence: 99%

Living with Uncertainty: Acting in the Best Interests of Women

AIDS Research and Treatment

Stein

2012

Self Cite

“…3,16 Despite this clear need for expanded choice in a FP menu, female barrier methods are often not promoted or available in such communities, and there is a documented provider bias based on the concept that women cannot successfully understand or use them. [17][18][19] This continuing health disparity takes on even greater importance because the female condom-a female barrier methodremains to date the only demonstrated highly efficacious, women-initiated option ensuring autonomous protection against sexually transmitted infection (STI)/HIV. The development of future multipurpose prevention technologies (MPTs) 20,21 will surely include female barrier methods as a mainstay; two recent trials confirmed a female-inserted, tenofovir-loaded vaginal ring to be effective in reducing risk of HIV, and development is underway for the ring to combine both contraceptive with disease-reducing properties.…”

mentioning

confidence: 99%

“This Method, I Think, Can Shed New Light”

Int Q Community Health Educ

Dévieux

Jean‐Gilles

et al. 2016

Improving the reproductive health of immigrant populations requires understanding the specific context of risk and need. As part of a field trial of the FemCap™, a woman-initiated cervical barrier contraceptive, we conducted postintervention focus group discussions (FGDs) with 20 women (five FGDs) of Haitian background, the majority of whom were born in Haiti and spoke Haitian Créole at home, at a community health center in south Florida. Participants discussed the role of religion and inequitable gender norms in Haitian traditions about family planning decisions and provided important insights into the gender-power nuances of their partnership dynamics vis à vis the use of female barrier methods. Encouraged by more equitable gender norms in the United States, participants were eager to serve as health education agents, with strong altruistic sentiments toward other Haitian girls and women who they felt could be encouraged to negotiate for greater reproductive decision-making power.

‘Men don't need to know everything’: a field trial of a discreet, female-initiated, contraceptive barrier method (FemCap™) among Haitian-American women

Culture, Health & Sexuality

Cyrus

Dévieux

et al. 2015

Worldwide, women report the need for safe, non-hormonal, woman-initiated methods of family planning. Cervical barriers provide such technology but are under-researched and under-promoted. In the USA, there are few studies of cervical barriers among women at high unmet need for contraception. A feasibility study of the FemCap™ was conducted among US women of Haitian origin. Participants were heterosexual and seeking to avoid pregnancy. At first visit, participants completed baseline assessments, underwent group counselling and were fitted with FemCap™. Women were asked to insert or use the cap at home. The second visit (2-3 weeks) included an interviewer-administered questionnaire and a focus-group discussion. Participants (n = 20) were Haitian-born (70%), married (55%) and parous (85%). Their mean age was 32.6 years. Seventy percent reported recent unprotected sex. All women inserted the device at home and 9 women used it during intercourse, including 5 without prior partner negotiation. Of 20 women, 11 liked FemCap™ very much or somewhat; 7 considered it 'OK'; 2 disliked it. Best-liked attributes were comfort, discreet wear and reusability. Difficulties with removal abated over time. Qualitative data revealed a high value placed on lack of systemic side effects. Use of FemCap™ was feasible and acceptable, supporting expansion of research, particularly among relevant populations with unmet need.